propranolol

(redirected from Innopran XL)
Also found in: Medical.
Related to Innopran XL: Inderal, propranolol

pro·pran·o·lol

 (prō-prăn′ə-lôl′, -lōl′, -lŏl′)
n.
A beta-blocker drug, C16H21NO2, used to treat hypertension, angina pectoris, cardiac arrhythmia, and certain kinds of tremors, and to prevent migraine headaches.

propranolol

(prəʊˈprænəˌlɒl)
n
(Pharmacology) a drug used in the treatment of angina pectoris, arrhythmia, hypertension, and some forms of tremor. Formula: C16H21NO2
[C20: from pro(pyl) + pr(op)anol (from propane + -ol) + -ol]

pro•pran•o•lol

(proʊˈpræn əˌlɔl, -ˌlɒl)

n.
a beta-blocking drug, C16H21NO2, used in the treatment of hypertension, angina pectoris, and cardiac arrhythmias.
[1960–65; pro (pyl) + pr(op)anol an isomer of propyl alcohol + -ol1]
Translations

propranolol

n propranolol m
References in periodicals archive ?
InnoPran XL is a beta-blocker and will be used in the treatment of hypertension.
To address patients' early morning susceptibility to cardiovascular events, InnoPran XL was developed as a chronotherapy using Eurand's Diffucaps technology.
March 13 /PRNewswire/ -- Reliant Pharmaceuticals, LLC announced today that the United States Food and Drug Administration (FDA) has approved InnoPran XL (propranolol hydrochloride), a novel bedtime-dosed, extended-release formulation of propranolol hydrochloride, for the treatment of hypertension.
InnoPran XL provides 24-hour blood pressure control in a once-daily formulation and a flexible dosing range from 80mg to 120 mg.
This brand, in combination with our currently marketed cardiovascular brands Lescol, Lescol XL, DynaCirc, DynaCirc CR and the recently approved InnoPran XL, substantially leverages our sales and marketing capacity.
The company recently received FDA approval for InnoPran XL, the first bedtime dosed beta-blocker for the treatment of hypertension.